PMID- 37865348 OWN - NLM STAT- MEDLINE DCOM- 20231123 LR - 20231204 IS - 1573-2517 (Electronic) IS - 0165-0327 (Linking) VI - 345 DP - 2024 Jan 15 TI - Association of serum individual and mixed aldehydes with depressive symptoms in the general population: A machine learning study. PG - 8-17 LID - S0165-0327(23)01313-7 [pii] LID - 10.1016/j.jad.2023.10.123 [doi] AB - BACKGROUND: Humans have many opportunities to be exposed to aldehydes which have potential mechanisms for causing depression. We aimed to explore the relationships between serum individual and mixed aldehydes with depressive symptoms in general population. METHODS: The data was extracted from the National Health and Nutrition Examination Survey 2013-2014. Depressive symptoms were assessed by Patient Health Questionnaire-9. Weighted binomial logistic regression and Bayesian kernel machine regression (BKMR) model were used to explore the association of six individual aldehyde and mixed aldehydes with depressive symptoms, respectively. Sex stratification analysis and sensitivity analysis were conducted. RESULTS: A total of 701 participants were included. We found a positive association between the highest (Q4) versus lowest quartile (Q1) of butyraldehyde with depressive symptoms (OR: 2.86, 95 % CI: 1.22-6.68), and a negative association between the Q3 versus Q1 of benzaldehyde (0.21, 0.07-0.60) and isopentanaldehyde (0.28, 0.08-0.90) with depressive symptoms in multivariate-adjusted model. The mixed aldehydes were positively associated with depressive symptoms using BKMR model, and butyraldehyde and heptanaldehyde were the dominant aldehydes. Several aldehydes, such as butyraldehyde and benzaldehyde, interacted with each other in their effects on depressive symptoms. The results of gender stratification analysis showed that butyraldehyde was the major contributor to the total effect of aldehydes on depressive symptoms in males, while heptanaldehyde was the dominant aldehyde in females. LIMITATIONS: Causality cannot be inferred in this cross-sectional study. CONCLUSIONS: Our study indicated that mixed aldehydes can increase the risk of depressive symptoms, of which butyraldehyde and heptanaldehyde were the major contributing aldehydes. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Ge, Lin AU - Ge L AD - Department of Epidemiology and Health Statistics, the School of Public Health of Qingdao University, No. 308 Ningxia Road, Qingdao 266071, China. FAU - Liu, Jin AU - Liu J AD - Department of Epidemiology and Health Statistics, the School of Public Health of Qingdao University, No. 308 Ningxia Road, Qingdao 266071, China. FAU - Kang, Xiao AU - Kang X AD - Department of Epidemiology and Health Statistics, the School of Public Health of Qingdao University, No. 308 Ningxia Road, Qingdao 266071, China. FAU - Wang, Weijing AU - Wang W AD - Department of Epidemiology and Health Statistics, the School of Public Health of Qingdao University, No. 308 Ningxia Road, Qingdao 266071, China. Electronic address: wangwj793@126.com. FAU - Zhang, Dongfeng AU - Zhang D AD - Department of Epidemiology and Health Statistics, the School of Public Health of Qingdao University, No. 308 Ningxia Road, Qingdao 266071, China. Electronic address: zhangdf1961@126.com. LA - eng PT - Journal Article DEP - 20231021 PL - Netherlands TA - J Affect Disord JT - Journal of affective disorders JID - 7906073 RN - H21352682A (butyraldehyde) RN - TA269SD04T (benzaldehyde) RN - 0 (Benzaldehydes) RN - 0 (Aldehydes) SB - IM MH - Male MH - Female MH - Humans MH - *Depression/etiology MH - *Benzaldehydes MH - Nutrition Surveys MH - Cross-Sectional Studies MH - Bayes Theorem MH - Aldehydes MH - Machine Learning OTO - NOTNLM OT - Aldehydes OT - BKMR OT - Depression OT - Depressive symptoms OT - Mixed exposure COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/10/22 00:41 MHDA- 2023/11/23 06:42 CRDT- 2023/10/21 19:32 PHST- 2023/08/10 00:00 [received] PHST- 2023/10/16 00:00 [revised] PHST- 2023/10/18 00:00 [accepted] PHST- 2023/11/23 06:42 [medline] PHST- 2023/10/22 00:41 [pubmed] PHST- 2023/10/21 19:32 [entrez] AID - S0165-0327(23)01313-7 [pii] AID - 10.1016/j.jad.2023.10.123 [doi] PST - ppublish SO - J Affect Disord. 2024 Jan 15;345:8-17. doi: 10.1016/j.jad.2023.10.123. Epub 2023 Oct 21.